Andrei Vinnik, Ph.D., CEO, co-founder

Andrei is a former Chief Trader of Norimet, a daughter company of Norilsk Nickel, in London. Norilsk Nickel is the world's leading producer of nickel and palladium, and one of the largest global producer of platinum and copper. He was in charge of building customer base and several billion USD of sales of precious metals including hedging strategies and commodity exchange trading. He has a Ph.D. in mathematics from Moscow Institute of Physics and Technology.

Peter Fedichev, Ph.D., Chief Scientific Officer, co-founder

Peter is a former assist. professor at the Institute for Theoretical Physics (Innsbruck University, Austria); author of over 40 scientific papers, PhD from the Univeristy of Amsterdam, worked at the FOM Institute for Molecular and Atomic Physics in Amsterdam and the Institute for Molecular Physics at Russian Research Center �Kurchatov Institute".

Peter's public profile@linkedin

Maxim Kholin, Director of Business Development and Legal Affairs, co-founder:

Maxim is a former deputy director for the Agency for Economic Partnership; 10 years of legal practice in corporate and intellectual property law; M.S. Degree from The Finance Academy, M.S. Degree from Moscow Law Academy.

Tatiana Alieva, Ph.D., Senior Scientific Officer, Drug Discovery & Biology Department

Tatiana holds M.S. degree, compeleted her Post-graduate study at Moscow Institute of Physics and Technology (MIPT) and recieved PhD in biophysics. She is a former ion channels drug discovery Researcher in the Institute of Pathology and Pathophysiology (Moscow).

Evgeny Getmantsev, Drug Design

Evgeny recieved M.S. degree from Moscow Institute of Electronic Technology. After more than 6 years of C++ software development Evgeny is in charge of QUANTUM software development and QUANTUM code optimization for massively parallel systems (inc. Blue Gene and Amazon EC3).